RXO, Inc.
RXO · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $4,550,000 | $3,927,000 | $4,796,000 | $4,689,000 |
| % Growth | 15.9% | -18.1% | 2.3% | – |
| Cost of Goods Sold | $3,767,000 | $3,202,000 | $3,936,000 | $3,954,000 |
| Gross Profit | $783,000 | $725,000 | $860,000 | $735,000 |
| % Margin | 17.2% | 18.5% | 17.9% | 15.7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $640,000 | $539,000 |
| Sales & Mktg Exp. | $0 | $0 | $640,000 | $539,000 |
| Other Operating Expenses | $839,000 | $686,000 | $97,000 | $4,000 |
| Operating Expenses | $839,000 | $686,000 | $737,000 | $543,000 |
| Operating Income | -$56,000 | $39,000 | $123,000 | $192,000 |
| % Margin | -1.2% | 1% | 2.6% | 4.1% |
| Other Income/Exp. Net | -$248,000 | -$35,000 | -$4,000 | -$1,000 |
| Pre-Tax Income | -$304,000 | $4,000 | $119,000 | $191,000 |
| Tax Expense | -$14,000 | $0 | $27,000 | $41,000 |
| Net Income | -$290,000 | $4,000 | $92,000 | $150,000 |
| % Margin | -6.4% | 0.1% | 1.9% | 3.2% |
| EPS | -2.17 | 0.034 | 0.79 | 1.29 |
| % Growth | -6,445% | -95.7% | -38.8% | – |
| EPS Diluted | -2.17 | 0.034 | 0.79 | 1.29 |
| Weighted Avg Shares Out | 133,412 | 116,871 | 116,400 | 116,400 |
| Weighted Avg Shares Out Dil | 133,412 | 119,456 | 116,400 | 116,400 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $30,000 | $32,000 | $4,000 | $0 |
| Depreciation & Amortization | $87,000 | $67,000 | $86,000 | $81,000 |
| EBITDA | $117,000 | $134,000 | $209,000 | $272,000 |
| % Margin | 2.6% | 3.4% | 4.4% | 5.8% |